A typical example, Ad-ΔB7-KOX (an oncolytic Adv expressing a transcriptional repressor targeting the VEGF promoter) effectively retains the tumor-selective effect of OVs and significantly inhibits VEGF in GBM, demonstrating enhanced antitumor effect and survival benefits (Kang et al., 2008). This evidence concerns the gene VEGFA and neoplasm.